Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in
communities with high COVID-19 rates. This new condition is heterogenous but resembles …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Background: Risk factors for severe outcomes of SARS-CoV-2 infection are not well
established in children. We sought to describe pediatric hospital admissions associated with …

Background Italy was the first Western country to be hit by the SARS-CoV-2 epidemic. There
is now mounting evidence that a minority of children infected with SARS-CoV2 may …

Objective A meta-analysis of laboratory cardiac markers for multisystem inflammatory
syndrome in children (MIS-C) was performed in patients with coronavirus disease 2019 …

Background To better inform clinical practice, we summarized the findings from randomized
controlled trials (RCTs) of antivirals for COVID-19. Methods We systematically searched for …

As the coronavirus disease 2019 (COVID-19) pandemic second wave is emerging, it is of
the upmost importance to screen the population immunity in order to keep track of infected …

Background Paediatric inflammatory multisystem syndrome (PIMS) is a rare condition
temporally associated with SARS-CoV-2 infection. Using national surveillance data, we …

Aims Multisystemic inflammatory syndrome in children (MIS‐C) is a condition noted in some
children asymptomatic but positive to Sars‐cov‐2 antibody and it presents clinical and …

Background. This study aimed to describe the clinical symptoms, laboratory findings,
treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory …